Joined June 2012
- Tweets 272
- Following 367
- Followers 259
- Likes 3,346
1 Photos and videos
GIVEAWAY with @pulsepot!
⭐️ 150k HEX giveaway ⭐️
- (50k #HEX each, 3 different winners)
All you have to do is:
⁃Like and retweet this post
The winners will be chosen July 31st, 2022❤️ this community is the sickest.
good luck 🍀
#HEX #PulseChain #PulseX
295
1,513
2,052
chessdoc retweeted
6 Oct 2021
The COSMIC-021 trial showed activity w/ cabozantinib plus atezolizumab in pts w/ locally advanced or mCRPC who have been previously treated, including patients with high-risk features. @neerajaiims @huntsmancancer @myESMO #ESMO2021 #lcsm ow.ly/Rcml50GlFUG
8
20
chessdoc retweeted
18 Aug 2021
1/ On the heels of @ASCO #ASCO21 plenary, we are happy to share the results of KEYNOTE-564 trial of adjuvant pembrolizumab in mRCC just published in @NEJM ! A step towards better outcomes for all our patients with kidney cancer!
nejm.org/doi/full/10.1056/NE…
@OncoAlert @tompowles1
19
161
494
chessdoc retweeted
Another amazing class of oncologists goes out into the world! We are proud of each of you and can’t wait to see you all succeed in your lives and career. 😍💖Presenting the 🎓 2021 @UABHemOncFellow Graduates!!! 🥂🎉 Drs. Sampat,Outlaw, Rangarajan and Bodine
1
6
35
chessdoc retweeted
8 Jun 2021
We had a blast today celebrating with our graduating class of 2021 🥳@UABHemOncFellow at @VABIRMINGHAM 🎓💖🙏🏽🤩 We are so proud of each and every one of you and wish you the best in life!!!
3
27
chessdoc retweeted
6 Jun 2021
Checkmate 649 published! @sloan_kettering ✅ @KoheiShitara #ASCO21 @ASCO Leading Phase III studies is fun! Thank you to all the patients and caregivers, to my amazing colleagues and @bmsnews @ScienceAtBMS thelancet.com/journals/lance…
24
98
333
chessdoc retweeted
9 Apr 2021
🚨⭐️Immunotherapy in non-small cell lung cancer harbouring driver mutations @Alfdoc2 @APassaroMD @UmbertoMalapel1 @gbanna74 @DralexGva @OncoAlert cancertreatmentreviews.com/a…
14
37
23 Jan 2021
Amazing paper!! @DevikaDasMD @notahedge
22 Jan 2021
A bioinformatics approach led us to a novel SCLC-Inflamed subtype (SCLC-I) that predicts greater benefit from immunotherapy. Excited to have this out @Cancer_Cell
bit.ly/397xNCn. Congrats Drs. Gay, Stewart, Park and our many collaborators. #LCSM #SCLC @MDAndersonNews
4
chessdoc retweeted
8 Jan 2021
Current state and future of research in nephrology by @Sunilrang and @anupamuab in @ackdonline
ow.ly/cREL50CTFSh
ow.ly/pCpv50CTFSi
6
20
chessdoc retweeted
30 Dec 2020
Despite COVID outbreak, treatment opportunities for aNSCLC💊💉🧬 have increased ⬆️even moved to early stage. Reduce access inequalities FDA/EMA is pending. This figure (not exhaustive) summarizes 2020. Progress continues with all our effort and thanks to patients💪🏻💪🏻 #lungcancer
9
101
242
In the phase 3 mRNA-1273 trial participants received 2 doses of vaccine or placebo 28 days apart. The mRNA-1273 vaccine showed 94.1% efficacy in preventing #SARSCoV2, including severe disease. #IDTwitter
24
529
1,267
chessdoc retweeted
15 Oct 2020
A meta-analysis found that although native kidney biopsy is an invasive diagnostic procedure, the rates of bleeding complications are low. Complications are more frequently seen after kidney biopsies of hospitalized patients with AKI. bit.ly/CJN04710420
1
40
99
chessdoc retweeted
18 Sep 2020
Just in @NEJM 👏👏Frontline maintenance "AVELUMAB" shows largest magnitude of OS benefit in the history of #bladdercancer medicine. Congrats to @tompowles1 and dear friend @PGrivasMDPhD for being the senior author in @NEJM phase 3 before turning 40 y/o👉bit.ly/3hAXo7C
7
112
274
chessdoc retweeted
14 Sep 2020
4 key slides from my talk on “How I Treat Newly Diagnosed Myeloma” at #ASHMHM20 @ASH_hematology meeting. @MayoCancerCare @MayoClinic @MayoMyeloma
12
84
205
chessdoc retweeted
28 Aug 2020
An exhaustive first of it's kind review of #onconephrology in the prestigious high impact journal @CAonline acsjournals.onlinelibrary.wi… with @McmahonBlaithin @UVANeph Mitch Rosner and @YaleMed Mark Perazella
5
13
63
chessdoc retweeted
From our Special Issue on #Proteoglycans: "Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression" is free online: bit.ly/39WnwYu
#virus #cancer #extracellularmatrix #glycosaminoglycan @sunilrang @jillian_richter
1
1
chessdoc retweeted
14 Aug 2020
There are at least 4 possible reasons why some people with COVID have little or no symptoms.
1) A rapid immune response that conquers the virus
2) Pre-existing cross reactive immunity
3) Genetic factors
4) Low viral load at time of infection
We have emerging data for each. 👇
113
4,122
9,844